Agilent reveals results of first Pharma Lab Leaders Survey

Skip to Navigation


  • Published: Jun 6, 2019
  • Source: Agilent Technologies
  • Suppliers: Agilent Technologies
  • Channels: Ion Chromatography / Gas Chromatography / Sample Preparation / Electrophoresis / HPLC / Laboratory Informatics / Detectors / Proteomics & Genomics / Base Peak / MRI Spectroscopy / Raman / Chemometrics & Informatics / NMR Knowledge Base / Atomic / X-ray Spectrometry / Proteomics / UV/Vis Spectroscopy / Infrared Spectroscopy

Agilent Technologies has announced the results of its first Pharma Lab Leaders Survey, looking to gather insights from pharmaceutical, biopharmaceutical and contract research laboratories in seven countries around the world.

Respondents comprised 650 laboratory managers, directors and supervisors from China, Germany, India, South Korea, Switzerland, Austria and the US. The laboratories surveyed are involved in a range of activities, from disease research to manufacturing. The market research firm Frost & Sullivan conducted the survey on Agilent’s behalf.

“We were extremely pleased that Agilent wanted to work with us again to explore the challenges and opportunities within this unique group of laboratories,” said Paljit Sohal, principal consultant, Frost & Sullivan. “It is important for companies like Agilent to take the time to understand their customers’ challenges as these insights can be vital, informing strategies moving forwards.”

Respondents highlighted their unique industry challenges and laboratory pain points, as well as goals for the future. Overall, the primary focus was on achieving quicker results (55%), superior quality (44%) and data integrity (43%). Over half of the respondents indicated that quality standards are getting more stringent in their laboratories, with over 80% finding that their current workflow requires further optimization.

The top strategies being deployed by lab leaders to more efficiently move drugs through the pipeline are:

  • buying more sophisticated instruments that deliver a greater degree of specificity (85%);
  • improving documentation of the sample chain of custody (70%);
  • employing better-qualified staff (56%).

“Agilent is dedicated to continually listening to customers to ensure their success,” said Lon Justice, vice president of sales, marketing and customer experience at Agilent. “With this survey, we enhance our learnings about key pharmaceutical laboratory challenges, goals and pain points, which have never before been quantifiable. With these insights, our teams will be able to continue to bring customer-focused solutions to market, to improve the science and economics of the labs we serve.”

“Interestingly, 32% of respondents stated that having easier-to-use instruments would improve their workflow,” Justice added. “The new InfinityLab iQ System, which is being launched at this week’s ASMS conference, and the recently launched 8860 and 8890 GC systems are both clear demonstrations of how Agilent is responding to these needs.”



Social Links

Share This Links

Bookmark and Share


Suppliers Selection
Societies Selection

Banner Ad

Click here to see
all job opportunities

Copyright Information

Interested in spectroscopy? Visit our sister site

Copyright © 2019 John Wiley & Sons, Inc. All Rights Reserved